Investor relations

We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life

We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.

Press Releases

All
Regulatory
2021-07-14
Regulatorisk
Första dag för handel med teckningsoptioner av serie TO1
2021-06-23
Regulatorisk
Emplicure har godkänts för notering på Nasdaq First North Growth Market
2021-06-22
Regulatorisk
Emplicures erbjudande övertecknat

Latest Reports

2021-06-02
Delårsrapport Q1 2021

Financial Calendar

August 20 2021
Interim Report Q2 2021
November 19 2021
Interim Report Q3 2021

IR contact

Torbjörn W. Larsson CEO
+46 (0)70-747 65 99 torbjorn.walkerlarsson@emplicure.com

Subscribe

Recieve press releases and reports via email.